0
Skip to Content
T-CURX - Pioneering in vivo CAR-T cell therapy
Home
Leadership Team
Board of Directors
Scientific Advisory Board
Our Science
Pipeline
News & Events
Careers
T-CURX - Pioneering in vivo CAR-T cell therapy
Home
Leadership Team
Board of Directors
Scientific Advisory Board
Our Science
Pipeline
News & Events
Careers
Home
Folder: About Us
Back
Leadership Team
Board of Directors
Scientific Advisory Board
Our Science
Pipeline
News & Events
Careers

Tailored strategies for improved control of CAR-T cells in multiple myeloma

Jan 29
Written by Mario Brkulj
Mario Brkulj
Previous
Previous

A universally applicable toolbox for single-molecule quantification of chimeric antigen receptors using linker-resolved dSTORM microscopy

Next
Next

Fine tuning towards the next generation of engineered T cells 

CAR-T Therapy Reimagined

Follow us on Social

Contact

T-CURX GmbH

Innovations- und Gründerzentrum Würzburg
Friedrich-Bergius-Ring 15
97076 Würzburg
Germany

Phone: +49-(0)-931-250-99-712
Email: info@t-curx.com

Legal

Imprint
Privacy Policy

Newsletter Block
This newsletter signup form needs a storage option. Edit the block and enter a storage location via the Storage tab.

Subscribe to our News

Thank you!